Deadline Extended for DMF Type III eCTD Submissions by FDA

USFDA Extended the Compliance date for the submission of type III Drug Master Files In eCTD for until May 5, 2020. The DMF Guidance recommends the DMF holders to update their DMFs annually. If your present DMF is in the paper format then transforming it into an eCTD would be really difficult, keeping in mind the deadline and the pace at which you need to work.